🎉 Celebrating 15 Glorious Years!
Join us at TopStockResearch as we celebrate our journey with an exclusive limited-time offer.


Price to Earning ratio Analysis of Aarti Pharmalabs Ltd. - Deep Dive


Latest FY PE
Period Ending - Mar-25

24.93


Poor PE
Period Ending - Mar-24
18.18

Indecisive PE
Growth
37.13 %
Trailing Twelve Months PE
Period Ending - Mar-25

30.25


Very Poor PE
PE Analysis of Aarti Pharmalabs Ltd.
P/E Ratio of Aarti Pharmalabs Ltd. with value of 30.25 shows that stock price is high compared to company earnings and may be overvalued.
PE Ratio of AARTIPHARM rose handsomely by 37.13 % this year.
PE Ratio of AARTIPHARM trending up for at least three Years.
PE Ratio with value of 0 was lowest in Year Mar-22 in last Five Years.
Latest PE Ratio with value of 24.93 is Greater than Average PE of 11.20 in last five years.
Other PE Related Info of AARTIPHARM that may interest you.
Aarti Pharmalabs Ltd. Overview
CodePricePrevious PricePrice ChangeSector
AARTIPHARM909.25925.251.73 % Drugs & Pharma
Fundamental AnalysisTechnical Analysis
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued.    more ..
Price to Earning Formula
   PE Screener
PE Related Ratios
PriceToSalesRatioPriceToBookRatioPriceToCashFlowRatio

Tsr Value Index
Very Low Value StockScreener
FY - Historical Price to Earning of Aarti Pharmalabs Ltd.
PeriodMar-25Mar-24Mar-23Mar-22Mar-21Mar-20
PE24.9318.1812.92000
Change37.13 %40.68 %
Price749.25434.95275.85000
Price Change72.26 %57.68 %
FY Chart of Price to Earning of Aarti Pharmalabs Ltd.
Understanding Price to Earning

Value Investing   eBook  

Free PDF eBook on Value Investing

Value Investing  eBook

Free PDF eBook on Value Investing